The MBIOT Program provides an innovative interdisciplinary curriculum combining hands on science, business/entrepreneurial training, and an immersive internship experience in the biotech industry. This combination of training sets our graduates apart and gives them a proven competitive edge in the job market. During 2020-2021, 2021-2022 and 2022-2023 academic years the MBIOT students interned at such companies and research labs as:

Johnson & Johnson, PA
Bayer, CA
Merck and Co., NJ, MA
Takeda Pharmaceuticals, MA
FUJIFILM Diosynth Biotechnologies, TX
Moderna, MA
Boehringe-Ingelheim, MO
Bristol-Myers Squibb, MA
Spotlight Therapeutics, CA
GlaxoSmithKline, PA, MD
Thermo Fisher Scientific, NJ
Regenxbio, MD
Paragon Bioservices, MD
InGeneron Inc., TX
MD Anderson Cancer Center, TX
Immunomet Therapeutics, TX
Clara Foods, CA
Regeneron Pharmaceuticals, Inc., NY
K2BIO, TX
Catalent Pharma Solutions, MD
BIOMARIN, CA
iBio CDMO, TX
Marker Therapeutics, TX
Institute of Pharmacology and Neurotherapeutics, Texas A&M University, TX
Dyno Therapeutics, MA
Kite Pharma, CA
Synthetic and Systems Biology Innovation Hub, Texas A&M University, TX
ATUM Bio, CA
Lonza Biologics, Inc., TX
National Center for Therapeutics Manufacturing, TX
Gilead Sciences, Inc., CA
Arvinas, Inc., CT
CND Life Sciences, AZ
Seres Therapeutics, MA
Exo Therapeutics, Inc., MA